These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC; Yang J; Zhao W; Perez LE; Cheng J Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143 [TBL] [Abstract][Full Text] [Related]
30. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Wanasen N; Xin L; Soong L Int J Parasitol; 2008 Mar; 38(3-4):417-29. PubMed ID: 17959178 [TBL] [Abstract][Full Text] [Related]
31. A Leishmania amastigote-specific hypothetical protein evaluated as recombinant protein plus Th1 adjuvant or DNA plasmid-based vaccine to protect against visceral leishmaniasis. Oliveira-da-Silva JA; Machado AS; Ramos FF; Tavares GSV; Lage DP; Mendonça DVC; Pereira IAG; Santos TTO; Martins VT; Carvalho LM; Freitas CS; Ludolf F; Reis TAR; Bandeira RS; Silva AM; Costa LE; Oliveira JS; Duarte MC; Roatt BM; Teixeira AL; Coelho EAF Cell Immunol; 2020 Oct; 356():104194. PubMed ID: 32827943 [TBL] [Abstract][Full Text] [Related]
32. Malaria-Cutaneous Leishmaniasis Co-infection: Influence on Disease Outcomes and Immune Response. Pinna RA; Silva-Dos-Santos D; Perce-da-Silva DS; Oliveira-Ferreira J; Villa-Verde DM; De Luca PM; Banic DM Front Microbiol; 2016; 7():982. PubMed ID: 27446022 [TBL] [Abstract][Full Text] [Related]
33. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745 [TBL] [Abstract][Full Text] [Related]
34. Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection. Costa LE; Chávez-Fumagalli MA; Martins VT; Duarte MC; Lage DP; Lima MI; Pereira NC; Soto M; Tavares CA; Goulart LR; Coelho EA Parasitology; 2015 Sep; 142(10):1335-47. PubMed ID: 26099574 [TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis. Chamakh-Ayari R; Bras-Gonçalves R; Bahi-Jaber N; Petitdidier E; Markikou-Ouni W; Aoun K; Moreno J; Carrillo E; Salotra P; Kaushal H; Negi NS; Arevalo J; Falconi-Agapito F; Privat A; Cruz M; Pagniez J; Papierok GM; Rhouma FB; Torres P; Lemesre JL; Chenik M; Meddeb-Garnaoui A PLoS One; 2014; 9(5):e92708. PubMed ID: 24786587 [TBL] [Abstract][Full Text] [Related]
36. Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. Stäger S; Smith DF; Kaye PM J Immunol; 2000 Dec; 165(12):7064-71. PubMed ID: 11120835 [TBL] [Abstract][Full Text] [Related]
37. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection. Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018 [TBL] [Abstract][Full Text] [Related]
39. Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis. Germanó MJ; Mackern-Oberti JP; Vitório JG; Duarte MC; Pimenta DC; Sanchez MV; Bruna FA; Lozano ES; Fernandes AP; Cargnelutti DE Front Immunol; 2022; 13():825007. PubMed ID: 35634280 [TBL] [Abstract][Full Text] [Related]
40. Ubiquitin conjugation of open reading frame F DNA vaccine leads to enhanced cell-mediated immune response and induces protection against both antimony-susceptible and -resistant strains of Leishmania donovani. Sharma A; Madhubala R J Immunol; 2009 Dec; 183(12):7719-31. PubMed ID: 19933862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]